Bausch and Glenmark announce approval of RYALTRIS in Canada
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Subscribe To Our Newsletter & Stay Updated